Litcius/Paper detail

Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity

Carolina Lucas, Chantal B. F. Vogels, İnci Yıldırım, Jessica E. Rothman, Peiwen Lu, Valter Silva Monteiro, Jeff Gehlhausen, Melissa Campbell, Julio Silva, Alexandra Tabachnikova, Mario A. Peña-Hernández, M. Catherine Muenker, Mallery I. Breban, Joseph R. Fauver, Subhasis Mohanty, Jiefang Huang, Yale SARS-CoV-2 Genomic Surveillance Initiative, Claire Pearson, Anthony Muyombwe, Randy Downing, Jafar Razeq, Mary E. Petrone, Isabel M. Ott, Anne E. Watkins, Chaney C. Kalinich, Tara Alpert, Anderson F. Brito, Rebecca Earnest, Steven Murphy, Caleb Neal, Éva László, Ahmad Altajar, Irina Tikhonova, Christopher Castaldi, Shrikant Mane, Kaya Bilgüvar, Nicholas Kerantzas, David Ferguson, Wade L. Schulz, Marie L. Landry, David R. Peaper, Albert C. Shaw, Albert I. Ko, Saad B. Omer, Nathan D. Grubaugh, Akiko Iwasaki

2021Nature261 citationsDOIOpen Access PDF

Topics & Concepts

NeutralizationAntibodyVirologyVaccinationImmunityNeutralizing antibodyBiologyImmune systemHumoral immunityImmunologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesAnimal Virus Infections Studies
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity | Litcius